During the past decade, Virginia Cancer Institute conducted 85 clinical trials. In the 10-year time frame, 85 clinical trials started and 64 clinical trials were completed, i.e. on average, 75.3% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 35 clinical trials were completed. i.e. 94.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Virginia Cancer Institute" #1 sponsor was "National Cancer Institute (NCI)" with 28 trials, followed by "SCRI Development Innovations, LLC" with 21 trials sponsored, "SWOG Cancer Research Network" with 18 trials sponsored, "Bristol-Myers Squibb" with 10 trials sponsored and "Alliance for Clinical Trials in Oncology" with 10 trials sponsored. Other sponsors include 66 different institutions and companies that sponsored additional 46 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Virginia Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 34 trials as a collaborator, "Genentech, Inc." with 7 trials as a collaborator, "Astellas Pharma Inc" with 3 trials as a collaborator, "Bayer" with 3 trials as a collaborator and "Bristol-Myers Squibb" with 3 trials as a collaborator. Other collaborators include 45 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Virginia Cancer Institute" are "Breast Cancer" (18 trials), "Pancreatic Cancer" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials) and "Non-Small Cell Lung Cancer" (6 trials). Many other conditions were trialed in "Virginia Cancer Institute" in a lesser frequency.

Most popular intervention types in "Virginia Cancer Institute" are "Drug" (130 trials), "Other" (54 trials), "Biological" (38 trials), "Procedure" (16 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (25 trials), "Laboratory Biomarker Analysis" (20 trials), "Carboplatin" (19 trials), "Paclitaxel" (17 trials) and "Placebo" (17 trials). Other intervention names were less common.

The vast majority of trials in "Virginia Cancer Institute" are 135 trials for "All" genders, 15 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Virginia Cancer Institute". undefined are not yet recruiting, 28 are recruiting, 40 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 70 completed trials in Virginia Cancer Institute, 3 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Virginia Cancer Institute, 2 "Phase 1" clinical trials were conducted, 73 "Phase 2" clinical trials and 76 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".

Virginia Cancer Institute has several departments that took part in Clinical trials: "Virginia Cancer Institute - West End" - 5 trials, "Virginia Cancer Institute" - 4 trials, "Virginia Cancer Institute ( Site 0052)" - 3 trials